Gilead Sciences · 3 days ago
Director, U.S. Public Affairs, HIV Communications
Parsippany, NJ
Full-time
Hybrid
Director/Executive
$210K/yr - $272K/yr
10+ years expGilead Sciences is committed to creating a healthier world for all people, focusing on tackling significant health challenges such as HIV. The Director, U.S. Public Affairs, HIV Communications will develop and execute comprehensive communication strategies for product launches, ensuring alignment with corporate objectives and enhancing Gilead's reputation in the HIV treatment landscape.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Develop a comprehensive U.S. launch strategy aligned with business objectives and public affairs priorities
Identify key public affairs messages, positioning, and tone for the product launch
Lead message testing efforts and support community listening sessions to confirm and inform positioning
Anticipate and work with cross functional government affairs, medical affairs and market access partners to support market shaping approach and drive positioning to support access
Identify and advance Gilead’s business priorities across the treatment landscape, while balancing treatment as part of the broader Gilead HIV story
Provide strategic counsel to senior leaders and external partners to ensure alignment with corporate objectives
Drive the success of the across the launch lifecycle (pre-launch, launch, post-launch) brand from a PA perspective ensuring high brand awareness and communicating the value as a significant regimen in the treatment market
Lead in the development, review, approval and execution of all launch communication materials in advance of FDA filing and potential approach, such as press materials, HCP and patient storytelling, executive training and talking points, paid partnerships
Oversee creation, training and briefing materials for key Gilead leaders, spokespeople and third-party voices
Advance integrated activation of paid, earned, owned and social communications at launch
Craft creative, targeted and differentiated storytelling strategy to capture key audiences, in key geographies at launch
Support communication of the new product within the broader portfolio
Amplify advocacy efforts to support the launch and advance Gilead’s reputation with community stakeholders
Contribute to any issues management planning and execution
Track key media coverage, sentiment analysis, stakeholder feedback
Ongoing communications strategy execution in line with launch and post – launch plan to continue the drumbeat and build Gilead’s reputation in HIV
Report against KPIs and ensure coordination with corporate reputation team
Oversee budget allocation for public affairs initiatives tied to HIV launch communications
Qualification
Required
Bachelor's degree in communications, or related field, business, public health or a science-related field, with at least 12+ years of relevant experience, or a master's degree with a minimum of 10+ years of experience
Experience leading public affairs communication planning and execution for a product launch in the biopharmaceutic sector
Proven ability to collaborate across internal teams and senior leaders in a highly matrixed organization, and to engage confidently with peers and executives to drive communications-related initiatives and to deliver complex initiatives aligned with shared goals
Proven ability to lead complex, cross-functional initiatives with significant organizational impact
Demonstrated experience, including managing projects or small teams, mentoring colleagues, and serving as a trusted advisor to peers and senior leadership
Exceptional communication skills (verbal, written, interpersonal) combined with creativity, collaboration, attention to detail, and strategic thinking
Experience supporting public health-related campaigns across multiple markets or regions
Demonstrated ability to differentiate an asset in a crowded marketplace based on the value that the medicine brings to patients and the community
Strong project management skills with experiencing coordinating cross-functional initiatives
Prior experience in biopharma communications, advocacy, marketing, reputation and issues management required
Demonstrated experience in issues management and crisis communications
Proven ability to influence senior leaders and external stakeholders, including third-party partners, through strategic advocacy and compelling communication
Experience using qualitative and quantitative insights to inform communications strategy and measure impact
Familiarity with digital platforms and tools for engagement and outreach
Commitment to advancing health equity and supporting initiatives that address disparities in care
Ability to develop and deliver internal training programs on communications best practices
Willingness to travel up to 30%
Preferred
Understanding of the HIV therapeutic area preferred
Demonstrated knowledge of regulations governing communications for a publicly traded biopharmaceutical company
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2026-01-16
FierceBiotech
2026-01-16
Company data provided by crunchbase